Abstract
The development of hybrid particles for tumor diagnosis and therapy has received considerable attention because they are capable of combining tumor diagnosis and treatment concurrently. So far hybrid particles for efficient and safe tumor theranostics are still very limited. Herein we have designed a new type of hybrid particles and evaluated its potential to be used in image-guided cancer diagnosis and therapy without the need of any toxic anticancer or contrast agents. The hybrid particles, consist of magnetic IP: 5.10.31.151 nanoparticles On: Mon, which09 areSep embedded 2019 05:20:33 in the poly(methyl methacrylate) (PMMA) cores and gold shells on chitosan (CTS)
| Original language | English |
|---|---|
| Pages (from-to) | 2072-2089 |
| Number of pages | 18 |
| Journal | Journal of Biomedical Nanotechnology |
| Volume | 15 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 1 Jan 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- CT Imaging
- Magnetic Targeting
- Multifunctional Hybrid Particles
- Photoacoustic Imaging
- Photothermal Therapy
- Tumor Theranostics
ASJC Scopus subject areas
- Bioengineering
- Medicine (miscellaneous)
- Biomedical Engineering
- General Materials Science
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Magnetic/gold core-shell hybrid particles for targeting and imaging-guided photothermal cancer therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver